Both in Biotechnology
Artiva Biotherapeutics vs Protalix BioTherapeutics
Over the past year ARTV returned +10.5% and PLX returned +5.9%; their daily moves had a correlation of 0.12.
ARTV +10.5% PLX +5.9%Growth of $1, one year, split-adjusted
| Metric | ARTV | PLX |
|---|---|---|
| Price | $4.17 | $2.53 |
| Market cap | $203.6M | $203.8M |
| Today | −0.60% | −1.17% |
| 1 month | −41.6% | −6.6% |
| 6 months | −60.7% | +29.1% |
| Year to date | −2.9% | +40.6% |
| 1 year | −0.1% | +6.8% |
| Revenue growth (YoY) | — | +27.1% |
| Gross margin | — | 61.0% |
| Net margin | — | 19.0% |
| P/E (TTM) | — | 10.8× |
| Price / sales | — | 2.5× |
| Net cash | $349.4M | $40.7M |
| Dividend yield | — | — |
| Volatility (60d) | 93.2% | 44.7% |
| Short % of float | 20.1% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).